Baoling Bio

company

About

Baoling Bio is a biomedical technology company engaged in innovative drug research and industrialization processes.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
¥106.50M
Industries
Biopharma,Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥106.50M
Baoling Bio has raised a total of ¥106.50M in funding over 2 rounds. Their latest funding was raised on Dec 8, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 8, 2021 Series A ¥106.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Baoling Bio is funded by 1 investors. New Value Capital are the most recent investors.
Investor Name Lead Investor Funding Round
New Value Capital Series A